등록된 논문 143건

※ 클릭시 해당 논문페이지로 이동합니다.

• KCSG ST22-06위암분과

  Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06)

  • 저널 BMC Cancer. 2024 Feb 23;24(1):252.
  • 제1저자 임성희
  • 교신저자 이근욱, 라선영

• KCSG PC21-07완화의료분과

  Clinical implication of megestrol acetate in metastatic gastric cancer: a big data analysis from Health Insurance Review and Assessment (HIRA) database

  • 저널 Support Care Cancer . 2024 Mar 26;32(4):249.
  • 제1저자 이창민, 강정훈
  • 교신저자 고세일

• KCSG BR15-17유방

  Pemetrexed plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer (KCSG-BR15-17): A randomized, open-label, multicenter, phase II trial

  • 저널 Eur J Cancer. 2024 Jan:197:113456.
  • 제1저자 이대원, 정경해
  • 교신저자 이경훈, 임석아

• KCSG LU19-04폐암

  Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)

  • 저널 J Clin Oncol. 2023 Oct 20:JCO2301891. Online ahead of print.
  • 제1저자 박세훈
  • 교신저자 안명주

• KCSG HN15-16두경부식도암

  Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial

  • 저널 J Clin Oncol. 2024 Feb 10;42(5):507-517.
  • 제1저자 김범석
  • 교신저자 윤환중, 김혜련, 김상우

• KCSG UN14-13희귀암

  A phase II study on the efficacy of regorafenib in treating patients with c-KIT-mutated metastatic malignant melanoma that progressed after previous treatment (KCSG-UN-14-13)

  • 저널 Eur J Cancer . 2023 Nov:193:113312. doi: 10.1016/j.ejca.2023.113312.
  • 제1저자 김규현, 정민규
  • 교신저자 신상준

• KCSG BR18-16유방암

  Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16)

  • 저널 Eur J Cancer . 2023 Dec:195:113386. doi: 10.1016/j.ejca.2023.113386.
  • 제1저자 김세현, 임석아
  • 교신저자 김지현

• KCSG LU19-04폐암

  Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)

  • 저널 J Clin Oncol . 2023 Oct 20 00:1-11
  • 제1저자 박세훈
  • 교신저자 안명주

• KCSG BR12-09유방암

  21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer

  • 저널 N Engl J Med 2021;385:2336-47.
  • 제1저자 유방암분과
  • 교신저자 유방암분과

• KCSG HN15-16두경부식도암

  A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC): In-Depth Analysis of Nintendanib Arm from the KCSG HN15-16 TRIUMPH Trial

  • 저널 Cancer Res Treat . 2023 Jul 20. doi: 10.4143/crt.2023.433.
  • 제1저자 김규현, 임선민
  • 교신저자 김진수

12345